Sexual HIV transmission risk behaviors associated with stimulant drug injection among people who non-medically use gabapentin and opioids

References

• Ahmad, F. B., Rossen, L. M., & Sutton, P. (2022). Provisional drug overdose death counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
   Google Scholar
• Alpren, C., Dawson, E. L., John, B., Cranston, K., Panneer, N., Fukada, D., Roosevelt, K., Klevens, M., Bryant, J., Peters, P. J., Lyss, S. B., Switzer, W. M., Burrage, A., Murray, A., Agnew-Brune, C., Stiles, T., McClung, P., Campbell, E. M., Breen, C. … Buchacz, K. (2020). Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs - Massachusetts, 2015-2018. American Journal of Public Health, 110(1), 37–44. https://doi.org/10.2105/AJPH.2019.305366
   PubMed Web of Science ®Google Scholar
• Buttram, M. E., & Kurtz, S. P. (2015). Characteristics associated with group sex participation among men and women in the club drug scene. Sexual Health, 12(6), 560–562. https://doi.org/10.1071/SH15071
   PubMed Web of Science ®Google Scholar
• Buttram, M. E., Kurtz, S. P., Cicero, T. J., & Havens, J. R. (2019). An ethnographic decision model of the initiation of gabapentin misuse among and/or illicit opioid (mis)users. Drug and Alcohol Dependence, 204, 107554. https://doi.org/10.1016/j.drugalcdep.2019.107554
   PubMed Web of Science ®Google Scholar
• Buttram, M. E., Pagano, M. E., & Kurtz, S. P. (2018). Frequency of group sex participation and risk for HIV/STI among young adult nightclub scene participants. International Journal of Sexual Health, 31(1), 12–19. https://doi.org/10.1080/19317611.2017.1385561
   Google Scholar
• Buttram, M. E., & Surratt, H. L. (2020). Factors associated with gabapentin misuse among people who inject drugs in Appalachian kentucky. Substance Use & Misuse, 55(14), 2364–2370. https://doi.org/10.1080/10826084.2020.1817082
   PubMed Web of Science ®Google Scholar
• Cepeda, J. A., Vickerman, P., Bruneau, J., Zang, G., Borquez, A., Farrell, M., Degenhardt, L., & Martin, N. K. (2020). Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis. Drug and Alcohol Dependence, 213, 108135. https://doi.org/10.1016/j.drugalcdep.2020.108135
   PubMed Web of Science ®Google Scholar
• Choi, N. G., DiNitto, D. M., Marti, C. N., & Choi, B. Y. (2021). U.S. older adults’ heroin and psychostimulant use treatment admissions, 2012–2019: Sociodemographic and clinical characteristics. Drug and Alcohol Dependence, 109256, 109256. https://doi.org/10.1016/j.drugalcdep.2021.109256
   Google Scholar
• Dennis, M. L. (2006). Global appraisal of individual needs. Version 5.4. Chestnut Health Systems.
   Google Scholar
• Ellis, M. S., Kasper, Z. A., & Cicero, T. J. (2018). Twin epidemics: The surging rise in methamphetamine use in chronic opioid users. Drug and Alcohol Dependence, 193, 14–20. https://doi.org/10.1016/j.drugalcdep.2018.08.029
   PubMed Web of Science ®Google Scholar
• Evoy, K. E., Covvey, J. R., Peckham, A. M., & Reveles, K. R. (2021). Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. International Journal of Clinical Pharmacy, 43(4), 1055–1064. https://doi.org/10.1007/s11096-020-01217-8
   PubMed Web of Science ®Google Scholar
• Friedman, S. R., Bolyard, M., Khan, M., Maslow, C., Sandoval, M., Mateu-Gelabert, P., Krauss, B., & Aral, S. O. (2008). Group sex events and HIV/STI risk in an urban network. Journal of Acquired Immune Deficiency Syndromes, 49(9), 440. https://doi.org/10.1097/QAI.0b013e3181893f31
   PubMedGoogle Scholar
• Friedman, S. R., Mateu-Gelabert, P., & Sandoval, M. (2011). Group sex events among non-gay drug users: An understudied risk environment. International Journal of Drug Policy, 22(1), 1–8. https://doi.org/10.1016/j.drugpo.2010.06.004
   PubMed Web of Science ®Google Scholar
• Glick, S. N., Burt, R., Kummer, K., Tinsley, J., Banta-Green, C., & Golden, M. R. (2018). Increasing methamphetamine injection among non-MSM who inject drugs in King County, Washington. Drug and Alcohol Dependence, 182, 86–92. https://doi.org/10.1016/j.drugalcdep.2017.10.011
   PubMed Web of Science ®Google Scholar
• Glick, S. N., Klein, K. S., Tinsley, J., & Golden, M. R. (2021). Increasing heroin-methamphetamine (goofball0 use and related morbidity among Seattle area people who inject drugs. American Journal on Addictions, 30(2), 183–191. https://doi.org/10.1111/ajad.13115
   PubMed Web of Science ®Google Scholar
• Golden, M. R., Lechtenberg, R., Glick, S. N., Dombrowski, J., Duchin, J., Reuer, J. R., Dhanireddy, S., Neme, S., & Buskin, S. E. (2019). Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. Morbidity and Mortality Weekly Report (MMWR) morbidity and Mortality Weekly Report (MMWR), 68(15), 344. https://doi.org/10.15585/mmwr.mm6815a2
   PubMed Web of Science ®Google Scholar
• Goodwin, R. D., Moeller, S. J., Zhu, J., Yarden, J., Ganzhorn, S., & Williams, J. M. (2021). The potential role of cocaine and heroin co-use in the opioid epidemic in the United States. Addictive Behaviors, 113, 106680. https://doi.org/10.1016/j.addbeh.2020.106680
   PubMed Web of Science ®Google Scholar
• Hodder, S. L., Feinberg, J., Strathdee, S. A., Shoptaw, S., Altice, F. L., Ortenzio, L., & Beyrer, C. (2021). The opioid crisis and HIV in the USA: Deadly synergies. The Lancet, 397(10279), 1139–1150. https://doi.org/10.1016/S0140-6736(21)00391-3
   PubMed Web of Science ®Google Scholar
• Jawa, R., Stein, M. D., Anderson, B., Liebschutz, J. M., Stewart, C., Phillips, K. T., & Barocas, J. A. (2021). Behavioral risk factors for HIV infection in hospitalized persons who co-use stimulants and opioids. AIDS and Behavior, 26(4), 1–9. https://doi.org/10.1007/s10461-021-03460-0
   PubMed Web of Science ®Google Scholar
• Lyss, S. B., Buchacz, K., McClung, R. P., Asher, A., & Oster, A. M. (2020). Responding to outbreaks of human immunodeficiency virus among persons who inject drugs - United States, 2016-2019: Perspectives on recent experience and lessons learned. The Journal of Infectious Diseases, 222(Supplement 5), S239–249. https://doi.org/10.1093/infdis/jiaa112
   PubMedGoogle Scholar
• O’Donnell, J., Gladden, R. M., Mattson, C. L., Hunter, C. T., & Davis, N. L. (2020). Vital Signs: Characteristics of drug overdose deaths involving opioids and stimulants - 24 states and the district of Columbia, January -June 2019. Morbidity and Mortality Weekly Report (MMWR) morbidity and Mortality Weekly Report (MMWR), 69(35), 1189–1197. https://doi.org/10.15585/mmwr.mm6935a1
   PubMed Web of Science ®Google Scholar
• Park, J. N., Weir, B. W., Allen, S. T., Chaulk, P., & Sherman, S. G. (2018). Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduction Journal, 15(1), 1–8. https://doi.org/10.1186/s12954-018-0240-z
   PubMedGoogle Scholar
• Schneider, K. E., White, R. H., Musci, R., O’Rourke, A., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020). The relationship between polysubstance injection drug use, HIV risk behaviors, and interest in pre-exposure prophylaxis (PrEP) among people who inject drugs in rural West Virginia. Journal of Studies on Alcohol and Drugs, 81(6), 740–749. https://doi.org/10.15288/jsad.2020.81.740
   PubMed Web of Science ®Google Scholar
• Surratt, H. L., Cowley, A. M., Gulley, J., Lockard, A. S., Otachi, J., Rains, R., & Williams, T. R. (2020). Syringe service program use among people who inject drugs in Appalachian Kentucky. American Journal of Public Health, 110(1), 34–36. https://doi.org/10.2105/AJPH.2019.305333
   PubMed Web of Science ®Google Scholar
• Warfield, S. C., Bharat, C., Bossarte, R. M., DePhilippis, D., Farrell, M., Hoover, M., Larney, S., Marchalek, P., McKetin, R., & Degenhardt, L. (2022). Trends in comorbid opioid and stimulant use disorders among veterans receiving care from the veterans health administration, 2005–2019. Drug and Alcohol Dependence, 232, 109310. https://doi.org/10.1016/j.drugalcdep.2022.109310
   PubMed Web of Science ®Google Scholar